Seviol Tablet 5/20 mg
Amlodipine Besylate · Olmesartan Medoxomil
Prescription medication · Combination
Jungheun Pharmaceutical Co., Ltd.
MFDS item code 201803056 · Approved 2018.07.24
This product's status changed to Expired on 2023.07.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
Amlodipine or Olmesartan Medoxomil is used when blood pressure is not adequately controlled in essential hypertension, which has no known cause. These drugs help control blood pressure by dilating blood vessels or lowering blood pressure. Proper management of blood pressure reduces the burden on the heart and blood vessels, thereby decreasing the risk of cardiovascular diseases. Thus, these drugs are effective in improving blood pressure control and treating hypertension.
Take 1 tablet once daily with water, regardless of meals. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40 mg. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The recommended doses are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or olmesartan medoxomil 20 mg monotherapy. - 10/20 mg: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 mg monotherapy. - 5/40 mg: For patients whose blood pressure is not adequately controlled with 5/20 mg. - 10/40 mg: For patients whose blood pressure is not adequately controlled with 5/40 mg. ∘Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 mg once daily. Use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with intravascular volume depletion: In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 mg once daily, and the maximum dose is 20 mg once daily. Patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics should be closely monitored for blood pressure and renal function. This medicine should not be administered to patients with severe hepatic impairment. (See section 2. Patients who should not receive this medicine under Precautions for Use.) ∘Elderly patients: Treatment should generally be initiated at a low dose. When adjusting the dose, the patient's renal or cardiac function and comorbidities should be taken into consideration. Blood pressure should be monitored closely and more frequently in elderly patients.
∘Children: The safety and efficacy in pediatric patients under 18 years of age have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used if there is an allergy to any of the ingredients, or if the patient is pregnant or breastfeeding, has severe liver impairment, aortic stenosis, bile duct obstruction, is undergoing dialysis, is in a state of shock, or has certain types of diabetes. Caution should be exercised when administering this medication to patients with hypotension due to lack of fluid or salt, patients at risk of rapid blood vessel dilation, patients with severe obstructive coronary artery disease, congestive heart failure, impaired kidney function, and patients with liver impairment; careful monitoring of their condition is necessary at the start of treatment. While taking this medication, various side effects such as dizziness, headache, hypotension, orthostatic hypotension, palpitations, nausea, vomiting, rash, and edema may occur, so if any abnormal symptoms appear, the patient should consult a doctor immediately. Although this medication is different from beta-blockers, caution should be taken when taken with other antihypertensive drugs, as it may lower blood pressure too much; particularly, kidney function or electrolyte status should be monitored regularly. Due to the potential risk to the fetus during pregnancy, patients planning to become pregnant or those who are pregnant should consult a doctor, and breastfeeding mothers should also carefully consider whether to take this medication, as it can pass into breast milk and affect the baby. It is advisable not to use this medication in children under 18 years of age, as its safety and efficacy have not been established. In elderly patients, renal and hepatic functions may be impaired, so starting with a lower dose and closely monitoring for side effects is recommended. In case of overdose, severe hypotension and symptoms due to vascular dilation may occur, so appropriate treatment should be sought immediately at a hospital. This medication should be stored away from light and moisture, out of reach of children, and it is advisable not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to keep it at room temperature, ideally between 1 degree and 30 degrees Celsius, avoiding extremes of temperature.
Round white film-coated tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate · Olmesartan Medoxomil
Prescription medication · Combination
Jungheun Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.